Different aspects of epileptic treatment - with focus on newer antiepileptic drug therapy
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.author | Rydmarker, Madeleine | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Aneszteziológiai és Intenzív Terápiás Tanszék | hu_HU |
| dc.date.accessioned | 2014-08-25T08:55:13Z | |
| dc.date.available | 2014-08-25T08:55:13Z | |
| dc.date.created | 2014-05-21 | |
| dc.description.abstract | With epilepsy being one of the most common neurological disorders, there is constant research hoping to find the most ideal antiepileptic drug therapy. Among the new antiepileptic drugs that exist today, the majority are used as an add-on therapy in combination with a standard therapy. Levetiracetam and Zonisamide are two of the newer drugs, each possessing its own unique features, that are widely used for partial as well as generalized epileptic seizures. | hu_HU |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 36 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/195822 | |
| dc.language.iso | en | hu_HU |
| dc.subject | Epilepsy | hu_HU |
| dc.subject | Levetiracetam | hu_HU |
| dc.subject | Zonisamide | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány::Farmakológia | hu_HU |
| dc.title | Different aspects of epileptic treatment - with focus on newer antiepileptic drug therapy | hu_HU |